(1->4)-beta-D-glucan multiple interactions ISO RGD:1331950 6480464 [perfluorooctane sulfonic acid co-treated with Cellulose] results in decreased expression of GPD1 mRNA CTD PMID:36331819 1,2-dimethylhydrazine decreases expression ISO RGD:1331950 6480464 1, 2-Dimethylhydrazine results in decreased expression of GPD1 mRNA CTD PMID:22206623 17beta-estradiol decreases expression ISO RGD:733156 6480464 Estradiol results in decreased expression of GPD1 mRNA CTD PMID:20106945 17beta-estradiol increases expression EXP 6480464 Estradiol results in increased expression of GPD1 mRNA CTD PMID:32145629 17beta-estradiol decreases expression ISO RGD:1331950 6480464 Estradiol results in decreased expression of GPD1 mRNA CTD PMID:19484750 17beta-hydroxy-17-methylestra-4,9,11-trien-3-one multiple interactions ISO RGD:1331950 6480464 Metribolone inhibits the reaction [Ketoconazole results in decreased expression of GPD1 mRNA] CTD PMID:19587329 2,3,7,8-tetrachlorodibenzodioxine affects expression EXP 6480464 Tetrachlorodibenzodioxin affects the expression of GPD1 mRNA CTD PMID:22298810 2,3,7,8-tetrachlorodibenzodioxine decreases expression ISO RGD:1331950 6480464 Tetrachlorodibenzodioxin results in decreased expression of GPD1 mRNA CTD PMID:28922406 2,3,7,8-tetrachlorodibenzodioxine decreases expression ISO RGD:733156 6480464 Tetrachlorodibenzodioxin results in decreased expression of GPD1 mRNA CTD PMID:20106945 more ... 2,3,7,8-tetrachlorodibenzodioxine increases activity ISO RGD:1331950 6480464 Tetrachlorodibenzodioxin results in increased activity of GPD1 protein CTD PMID:10497882 2,3,7,8-tetrachlorodibenzodioxine multiple interactions ISO RGD:1331950 6480464 Tetrachlorodibenzodioxin inhibits the reaction [Dehydroepiandrosterone results in increased activity of GPD1 protein] CTD PMID:10497882 2,4-dinitrotoluene decreases expression ISO RGD:1331950 6480464 2, 4-dinitrotoluene results in decreased expression of GPD1 mRNA CTD PMID:24893713 3-aminobenzoic acid multiple interactions ISO RGD:1331950 6480464 [INS1 protein co-treated with 3-aminobenzoic acid] results in increased activity of GPD1 protein CTD PMID:2523799 3-chloropropane-1,2-diol decreases expression EXP 6480464 alpha-Chlorohydrin analog results in decreased expression of GPD1 protein, alpha-Chlorohydrin results in decreased expression of GPD1 protein CTD PMID:26597043 3-isobutyl-1-methyl-7H-xanthine multiple interactions ISO RGD:1331950 6480464 [INS1 protein co-treated with Dexamethasone co-treated with 1-Methyl-3-isobutylxanthine] results in increased activity of GPD1 protein more ... CTD PMID:11101056 , PMID:2523799 3-isobutyl-1-methyl-7H-xanthine multiple interactions ISO RGD:733156 6480464 [INS protein co-treated with Dexamethasone co-treated with 1-Methyl-3-isobutylxanthine co-treated with Indomethacin] results in increased expression of GPD1 mRNA CTD PMID:28628672 3H-1,2-dithiole-3-thione increases expression EXP 6480464 1, 2-dithiol-3-thione results in increased expression of GPD1 mRNA CTD PMID:19162173 4,4'-sulfonyldiphenol increases expression ISO RGD:733156 6480464 bis(4-hydroxyphenyl)sulfone results in increased expression of GPD1 mRNA, bis(4-hydroxyphenyl)sulfone results in increased expression of GPD1 protein CTD PMID:27685785 , PMID:34186270 6-propyl-2-thiouracil decreases expression EXP 6480464 Propylthiouracil results in decreased expression of GPD1 mRNA CTD PMID:24780913 , PMID:25825206 aflatoxin B1 affects expression ISO RGD:733156 6480464 Aflatoxin B1 affects the expression of GPD1 protein CTD PMID:20106945 aflatoxin B1 increases expression EXP 6480464 Aflatoxin B1 results in increased expression of GPD1 mRNA CTD PMID:33354967 aflatoxin B1 increases methylation ISO RGD:733156 6480464 Aflatoxin B1 results in increased methylation of GPD1 intron CTD PMID:30157460 aflatoxin B1 decreases expression ISO RGD:733156 6480464 Aflatoxin B1 results in decreased expression of GPD1 mRNA CTD PMID:21641981 more ... aldehydo-D-glucose increases expression EXP 6480464 Glucose results in increased expression of GPD1 mRNA CTD PMID:3299706 all-trans-retinoic acid decreases expression ISO RGD:1331950 6480464 Tretinoin results in decreased expression of GPD1 mRNA CTD PMID:16604517 aluminium atom multiple interactions ISO RGD:733156 6480464 Aluminum results in increased expression of and results in increased activity of GPD1 protein CTD PMID:17762189 aluminium(0) multiple interactions ISO RGD:733156 6480464 Aluminum results in increased expression of and results in increased activity of GPD1 protein CTD PMID:17762189 ammonium chloride affects expression EXP 6480464 Ammonium Chloride affects the expression of GPD1 mRNA CTD PMID:16483693 aristolochic acid A increases expression ISO RGD:733156 6480464 aristolochic acid I results in increased expression of GPD1 mRNA CTD PMID:33212167 arsenous acid multiple interactions ISO RGD:733156 6480464 Arsenic Trioxide inhibits the reaction [4-aminophenylarsenoxide binds to GPD1 protein] CTD PMID:26598702 benzamide multiple interactions ISO RGD:1331950 6480464 [INS1 protein co-treated with benzamide] results in increased activity of GPD1 protein more ... CTD PMID:2523799 benzo[a]pyrene decreases expression ISO RGD:733156 6480464 Benzo(a)pyrene results in decreased expression of GPD1 mRNA CTD PMID:20106945 , PMID:32234424 benzo[a]pyrene increases methylation ISO RGD:733156 6480464 Benzo(a)pyrene results in increased methylation of GPD1 3' UTR, Benzo(a)pyrene results in increased methylation of GPD1 5' UTR CTD PMID:27901495 benzo[a]pyrene affects methylation ISO RGD:733156 6480464 Benzo(a)pyrene affects the methylation of GPD1 promoter CTD PMID:27901495 benzo[a]pyrene decreases expression ISO RGD:1331950 6480464 Benzo(a)pyrene results in decreased expression of GPD1 mRNA CTD PMID:22228805 benzo[a]pyrene multiple interactions ISO RGD:1331950 6480464 AHR protein affects the reaction [Benzo(a)pyrene affects the expression of GPD1 mRNA] CTD PMID:22228805 benzo[b]fluoranthene decreases expression ISO RGD:1331950 6480464 benzo(b)fluoranthene results in decreased expression of GPD1 mRNA CTD PMID:26377693 benzo[e]pyrene increases methylation ISO RGD:733156 6480464 benzo(e)pyrene results in increased methylation of GPD1 intron CTD PMID:30157460 benzoates multiple interactions ISO RGD:1331950 6480464 [INS1 protein co-treated with Benzoates] results in increased activity of GPD1 protein CTD PMID:2523799 bexarotene increases expression EXP 6480464 bexarotene results in increased expression of GPD1 mRNA CTD PMID:23292798 bezafibrate increases expression ISO RGD:1331950 6480464 Bezafibrate results in increased expression of GPD1 mRNA CTD PMID:1976021 bezafibrate multiple interactions ISO RGD:1331950 6480464 Bucladesine promotes the reaction [Bezafibrate results in increased expression of GPD1 mRNA] CTD PMID:1976021 bicalutamide decreases expression ISO RGD:1331950 6480464 bicalutamide results in decreased expression of GPD1 mRNA CTD PMID:19587329 bicalutamide multiple interactions ISO RGD:1331950 6480464 FSHB protein inhibits the reaction [bicalutamide results in decreased expression of GPD1 protein] CTD PMID:19587329 bisphenol A affects expression EXP 6480464 bisphenol A affects the expression of GPD1 mRNA CTD PMID:25181051 , PMID:30903817 bisphenol A decreases expression ISO RGD:733156 6480464 bisphenol A results in decreased expression of GPD1 protein CTD PMID:34186270 bisphenol A increases expression ISO RGD:1331950 6480464 bisphenol A results in increased expression of GPD1 mRNA CTD PMID:32156529 bisphenol A decreases expression ISO RGD:1331950 6480464 bisphenol A results in decreased expression of GPD1 mRNA CTD PMID:33221593 bisphenol A decreases expression EXP 6480464 bisphenol A results in decreased expression of GPD1 mRNA CTD PMID:30816183 Bisphenol B increases expression ISO RGD:733156 6480464 bisphenol B results in increased expression of GPD1 protein CTD PMID:34186270 bisphenol F increases expression ISO RGD:733156 6480464 bisphenol F results in increased expression of GPD1 protein CTD PMID:34186270 bromobenzene affects binding EXP 6480464 bromobenzene metabolite binds to GPD1 protein CTD PMID:17305373 bucladesine multiple interactions ISO RGD:1331950 6480464 Bucladesine promotes the reaction [Bezafibrate results in increased expression of GPD1 mRNA] CTD PMID:1976021 buspirone decreases expression EXP 6480464 Buspirone results in decreased expression of GPD1 mRNA CTD PMID:24136188 cadmium atom decreases activity ISO RGD:1331950 6480464 Cadmium results in decreased activity of GPD1 protein CTD PMID:21848503 cadmium atom multiple interactions ISO RGD:733156 6480464 [Cadmium Chloride results in increased abundance of Cadmium] which results in increased expression of GPD1 mRNA CTD PMID:35301059 cadmium dichloride decreases expression EXP 6480464 Cadmium Chloride results in decreased expression of GPD1 mRNA CTD PMID:25993096 cadmium dichloride multiple interactions ISO RGD:733156 6480464 [Cadmium Chloride results in increased abundance of Cadmium] which results in increased expression of GPD1 mRNA CTD PMID:35301059 carbon nanotube decreases expression ISO RGD:1331950 6480464 Nanotubes, Carbon analog results in decreased expression of GPD1 mRNA CTD PMID:25554681 celastrol affects activity ISO RGD:1331950 6480464 celastrol affects the activity of GPD1 protein CTD PMID:27085773 chlordecone increases expression ISO RGD:1331950 6480464 Chlordecone results in increased expression of GPD1 mRNA CTD PMID:33711761 cisplatin multiple interactions ISO RGD:733156 6480464 [Cisplatin co-treated with jinfukang] results in decreased expression of GPD1 mRNA CTD PMID:27392435 clobetasol increases expression ISO RGD:1331950 6480464 Clobetasol results in increased expression of GPD1 mRNA CTD PMID:27462272 clofibrate multiple interactions ISO RGD:1331950 6480464 [Clofibrate co-treated with Acetaminophen] affects the expression of GPD1 mRNA, PPARA affects the reaction [[Clofibrate co-treated with Acetaminophen] affects the expression of GPD1 mRNA] CTD PMID:17585979 clofibrate increases expression ISO RGD:1331950 6480464 Clofibrate results in increased expression of GPD1 mRNA CTD PMID:23811191 clofibrate increases expression EXP 6480464 Clofibrate results in increased expression of GPD1 mRNA, Clofibrate results in increased expression of GPD1 protein CTD PMID:12851107 , PMID:16470657 cobalt dichloride decreases expression EXP 6480464 cobaltous chloride results in decreased expression of GPD1 mRNA CTD PMID:24386269 Cuprizon decreases expression EXP 6480464 Cuprizone results in decreased expression of GPD1 mRNA CTD PMID:26577399 , PMID:27523638 cyclosporin A decreases expression ISO RGD:733156 6480464 Cyclosporine results in decreased expression of GPD1 mRNA CTD PMID:20106945 cyproconazole decreases expression ISO RGD:733156 6480464 cyproconazole results in decreased expression of GPD1 protein CTD PMID:29995386 D-glucose increases expression EXP 6480464 Glucose results in increased expression of GPD1 mRNA CTD PMID:3299706 dehydroepiandrosterone increases activity ISO RGD:1331950 6480464 Dehydroepiandrosterone results in increased activity of GPD1 protein CTD PMID:10497882 dehydroepiandrosterone multiple interactions ISO RGD:1331950 6480464 benz(a)anthracene inhibits the reaction [Dehydroepiandrosterone results in increased activity of GPD1 protein], Tetrachlorodibenzodioxin inhibits the reaction [Dehydroepiandrosterone results in increased activity of GPD1 protein] CTD PMID:10497882 dexamethasone multiple interactions ISO RGD:1331950 6480464 [INS1 protein co-treated with Dexamethasone co-treated with 1-Methyl-3-isobutylxanthine] results in increased activity of GPD1 protein more ... CTD PMID:11101056 , PMID:2523799 dexamethasone multiple interactions ISO RGD:733156 6480464 [INS protein co-treated with Dexamethasone co-treated with 1-Methyl-3-isobutylxanthine co-treated with Indomethacin] results in increased expression of GPD1 mRNA CTD PMID:28628672 dexamethasone increases expression ISO RGD:733156 6480464 Dexamethasone results in increased expression of GPD1 mRNA CTD PMID:25047013 diarsenic trioxide multiple interactions ISO RGD:733156 6480464 Arsenic Trioxide inhibits the reaction [4-aminophenylarsenoxide binds to GPD1 protein] CTD PMID:26598702 dibutyl phthalate decreases expression EXP 6480464 Dibutyl Phthalate results in decreased expression of GPD1 mRNA CTD PMID:21266533 dichloroacetic acid increases expression ISO RGD:1331950 6480464 Dichloroacetic Acid results in increased expression of GPD1 mRNA CTD PMID:28962523 diclofenac multiple interactions EXP 6480464 Diclofenac inhibits the reaction [lipopolysaccharide, E coli O55-B5 results in increased expression of GPD1 protein] CTD PMID:25772430 diethylstilbestrol increases expression EXP 6480464 Diethylstilbestrol results in increased expression of GPD1 mRNA CTD PMID:37077353 diquat increases expression ISO RGD:1331950 6480464 Diquat results in increased expression of GPD1 mRNA CTD PMID:36851058 diuron decreases expression EXP 6480464 Diuron results in decreased expression of GPD1 mRNA CTD PMID:25152437 epoxiconazole increases expression EXP 6480464 epoxiconazole results in increased expression of GPD1 mRNA CTD PMID:29038839 epoxiconazole decreases expression ISO RGD:1331950 6480464 epoxiconazole results in decreased expression of GPD1 mRNA CTD PMID:35436446 ethanol decreases expression ISO RGD:1331950 6480464 Ethanol results in decreased expression of GPD1 mRNA CTD PMID:15513904 fluoxetine increases expression EXP 6480464 Fluoxetine results in increased expression of GPD1 mRNA CTD PMID:17033635 flutamide increases expression EXP 6480464 Flutamide results in increased expression of GPD1 mRNA CTD PMID:24136188 fructose increases expression EXP 6480464 Fructose results in increased expression of GPD1 mRNA CTD PMID:36049592 furan increases methylation EXP 6480464 furan results in increased methylation of GPD1 gene CTD PMID:22079235 furan affects binding EXP 6480464 furan binds to GPD1 protein CTD PMID:22240984 genistein decreases expression ISO RGD:1331950 6480464 Genistein results in decreased expression of GPD1 mRNA CTD PMID:32186404 glucose increases expression EXP 6480464 Glucose results in increased expression of GPD1 mRNA CTD PMID:3299706 glycidol decreases expression EXP 6480464 glycidol results in decreased expression of GPD1 mRNA CTD PMID:24915197 hydrazines decreases expression ISO RGD:1331950 6480464 Hydrazines results in decreased expression of GPD1 mRNA CTD PMID:21647536 hydrogen cyanide decreases expression ISO RGD:1331950 6480464 Hydrogen Cyanide results in decreased expression of GPD1 mRNA CTD PMID:33914522 Indeno[1,2,3-cd]pyrene decreases expression ISO RGD:1331950 6480464 indeno(1 more ... CTD PMID:26377693 indometacin multiple interactions ISO RGD:733156 6480464 [INS protein co-treated with Dexamethasone co-treated with 1-Methyl-3-isobutylxanthine co-treated with Indomethacin] results in increased expression of GPD1 mRNA CTD PMID:28628672 ketoconazole decreases expression ISO RGD:1331950 6480464 Ketoconazole results in decreased expression of GPD1 mRNA CTD PMID:19587329 ketoconazole increases expression EXP 6480464 Ketoconazole results in increased expression of GPD1 mRNA CTD PMID:37077353 ketoconazole multiple interactions ISO RGD:1331950 6480464 Ketoconazole inhibits the reaction [FSHB protein results in increased expression of GPD1 mRNA], Metribolone inhibits the reaction [Ketoconazole results in decreased expression of GPD1 mRNA] CTD PMID:19587329 L-ascorbic acid multiple interactions EXP 6480464 [Ascorbic Acid co-treated with INS1 protein] results in decreased expression of GPD1 mRNA CTD PMID:20400526 lead diacetate increases expression EXP 6480464 lead acetate results in increased expression of GPD1 mRNA CTD PMID:22641619 leflunomide decreases expression ISO RGD:1331950 6480464 leflunomide results in decreased expression of GPD1 mRNA CTD PMID:19751817 levofloxacin decreases expression EXP 6480464 Levofloxacin results in decreased expression of GPD1 mRNA CTD PMID:24136188 lithium atom increases activity EXP 6480464 Lithium results in increased activity of GPD1 protein CTD PMID:3224025 lithium hydride increases activity EXP 6480464 Lithium results in increased activity of GPD1 protein CTD PMID:3224025 methapyrilene increases methylation ISO RGD:733156 6480464 Methapyrilene results in increased methylation of GPD1 intron CTD PMID:30157460 Methylazoxymethanol acetate increases expression EXP 6480464 Methylazoxymethanol Acetate results in increased expression of GPD1 mRNA CTD PMID:28349193 mono(2-ethylhexyl) phthalate increases expression ISO RGD:1331950 6480464 mono-(2-ethylhexyl)phthalate results in increased expression of GPD1 protein CTD PMID:27384973 N-nitrosomorpholine affects expression EXP 6480464 N-nitrosomorpholine affects the expression of GPD1 protein CTD PMID:19716841 nefazodone increases expression EXP 6480464 nefazodone results in increased expression of GPD1 mRNA CTD PMID:24136188 nickel atom decreases expression ISO RGD:733156 6480464 Nickel results in decreased expression of GPD1 mRNA CTD PMID:24768652 , PMID:25583101 nicotinic acid multiple interactions ISO RGD:1331950 6480464 [INS1 protein co-treated with Niacin] results in increased activity of GPD1 protein CTD PMID:2523799 nitrofen increases expression EXP 6480464 nitrofen results in increased expression of GPD1 mRNA CTD PMID:33484710 Nonylphenol decreases expression EXP 6480464 nonylphenol results in decreased expression of GPD1 protein CTD PMID:19260726 O-methyleugenol decreases expression ISO RGD:733156 6480464 methyleugenol results in decreased expression of GPD1 mRNA CTD PMID:32234424 obeticholic acid decreases expression ISO RGD:733156 6480464 obeticholic acid results in decreased expression of GPD1 mRNA CTD PMID:27939613 oxaliplatin increases expression EXP 6480464 oxaliplatin results in increased expression of GPD1 mRNA CTD PMID:25729387 paracetamol multiple interactions ISO RGD:1331950 6480464 [Clofibrate co-treated with Acetaminophen] affects the expression of GPD1 mRNA, PPARA affects the reaction [[Clofibrate co-treated with Acetaminophen] affects the expression of GPD1 mRNA] CTD PMID:17585979 paracetamol decreases expression ISO RGD:1331950 6480464 Acetaminophen results in decreased expression of GPD1 protein CTD PMID:22939915 paracetamol decreases expression ISO RGD:733156 6480464 Acetaminophen results in decreased expression of GPD1 mRNA CTD PMID:21420995 paraquat decreases expression EXP 6480464 Paraquat results in decreased expression of GPD1 mRNA CTD PMID:32680482 perfluorododecanoic acid increases expression EXP 6480464 perfluorododecanoic acid results in increased expression of GPD1 protein CTD PMID:26168851 perfluorononanoic acid decreases expression ISO RGD:733156 6480464 perfluoro-n-nonanoic acid results in decreased expression of GPD1 mRNA CTD PMID:32588087 perfluorooctane-1-sulfonic acid increases expression EXP 6480464 perfluorooctane sulfonic acid results in increased expression of GPD1 mRNA CTD PMID:19162173 perfluorooctane-1-sulfonic acid multiple interactions ISO RGD:1331950 6480464 [perfluorooctane sulfonic acid co-treated with Cellulose] results in decreased expression of GPD1 mRNA, [perfluorooctane sulfonic acid co-treated with Pectins] results in decreased expression of GPD1 mRNA CTD PMID:36331819 perfluorooctane-1-sulfonic acid decreases expression ISO RGD:733156 6480464 perfluorooctane sulfonic acid results in decreased expression of GPD1 mRNA CTD PMID:32588087 perfluorooctanoic acid increases expression EXP 6480464 perfluorooctanoic acid results in increased expression of GPD1 mRNA, perfluorooctanoic acid results in increased expression of GPD1 protein CTD PMID:16221955 , PMID:34958885 permethrin increases expression EXP 6480464 Permethrin results in increased expression of GPD1 mRNA CTD PMID:19017407 phorbol 13-acetate 12-myristate multiple interactions ISO RGD:1331950 6480464 Tetradecanoylphorbol Acetate inhibits the reaction [[INS1 protein co-treated with benzamide] results in increased activity of GPD1 protein] CTD PMID:2523799 picrotoxin decreases expression EXP 6480464 Picrotoxin results in decreased expression of GPD1 mRNA CTD PMID:15170462 pirinixic acid multiple interactions ISO RGD:1331950 6480464 [pirinixic acid binds to and results in increased activity of PPARA protein] which results in increased expression of GPD1 mRNA CTD PMID:19710929 pirinixic acid increases expression ISO RGD:1331950 6480464 pirinixic acid results in increased expression of GPD1 mRNA CTD PMID:16357043 more ... pirinixic acid increases expression EXP 6480464 pirinixic acid results in increased expression of GPD1 mRNA CTD PMID:19162173 , PMID:22484513 potassium cyanide increases expression ISO RGD:1331950 6480464 Potassium Cyanide results in increased expression of GPD1 mRNA CTD PMID:33914522 pregnenolone 16alpha-carbonitrile decreases expression ISO RGD:1331950 6480464 Pregnenolone Carbonitrile results in decreased expression of GPD1 mRNA CTD PMID:28903501 progesterone affects expression ISO RGD:1331950 6480464 Progesterone affects the expression of GPD1 mRNA CTD PMID:17251523 propiconazole multiple interactions ISO RGD:733156 6480464 [propiconazole co-treated with tebuconazole] results in increased expression of GPD1 mRNA CTD PMID:30989312 propiconazole decreases expression ISO RGD:733156 6480464 propiconazole results in decreased expression of GPD1 mRNA CTD PMID:30989312 resveratrol multiple interactions EXP 6480464 [resveratrol co-treated with Streptozocin] results in decreased expression of GPD1 mRNA CTD PMID:25905778 resveratrol multiple interactions ISO RGD:733156 6480464 [Plant Extracts co-treated with Resveratrol] results in decreased expression of GPD1 mRNA CTD PMID:23557933 ritonavir multiple interactions ISO RGD:1331950 6480464 Ritonavir promotes the reaction [[INS1 protein co-treated with Dexamethasone co-treated with 1-Methyl-3-isobutylxanthine] results in increased expression of GPD1 protein] CTD PMID:11101056 rotenone increases expression EXP 6480464 Rotenone results in increased expression of GPD1 mRNA CTD PMID:28374803 sodium arsenite increases expression ISO RGD:1331950 6480464 sodium arsenite results in increased expression of GPD1 protein CTD PMID:29044176 sodium arsenite decreases expression ISO RGD:733156 6480464 sodium arsenite results in decreased expression of GPD1 mRNA CTD PMID:29301061 sodium arsenite increases expression EXP 6480464 sodium arsenite results in increased expression of GPD1 protein CTD PMID:29459688 streptozocin multiple interactions EXP 6480464 [resveratrol co-treated with Streptozocin] results in decreased expression of GPD1 mRNA CTD PMID:25905778 sunitinib decreases expression ISO RGD:733156 6480464 Sunitinib results in decreased expression of GPD1 mRNA CTD PMID:31533062 tebuconazole multiple interactions ISO RGD:733156 6480464 [propiconazole co-treated with tebuconazole] results in increased expression of GPD1 mRNA CTD PMID:30989312 tebuconazole increases expression ISO RGD:733156 6480464 tebuconazole results in increased expression of GPD1 mRNA CTD PMID:30989312 Tesaglitazar increases expression EXP 6480464 tesaglitazar results in increased expression of GPD1 mRNA CTD PMID:21515302 testosterone increases expression ISO RGD:733156 6480464 Testosterone results in increased expression of GPD1 mRNA CTD PMID:33359661 tetracycline decreases expression ISO RGD:1331950 6480464 Tetracycline results in decreased expression of GPD1 mRNA CTD PMID:24489787 tetraphene multiple interactions ISO RGD:1331950 6480464 benz(a)anthracene inhibits the reaction [Dehydroepiandrosterone results in increased activity of GPD1 protein] CTD PMID:10497882 tetraphene increases activity ISO RGD:1331950 6480464 benz(a)anthracene results in increased activity of GPD1 protein CTD PMID:10497882 thapsigargin increases expression EXP 6480464 Thapsigargin results in increased expression of GPD1 protein CTD PMID:35544339 topotecan increases expression EXP 6480464 Topotecan results in increased expression of GPD1 mRNA CTD PMID:25729387 triptonide increases expression ISO RGD:1331950 6480464 triptonide results in increased expression of GPD1 mRNA CTD PMID:33045310 tris(2-butoxyethyl) phosphate affects expression ISO RGD:733156 6480464 tris(2-butoxyethyl) phosphate affects the expression of GPD1 mRNA CTD PMID:29024780 triticonazole increases expression EXP 6480464 triticonazole results in increased expression of GPD1 mRNA CTD PMID:36084822 troglitazone increases expression EXP 6480464 troglitazone results in increased expression of GPD1 protein CTD PMID:21315101 urethane decreases expression ISO RGD:733156 6480464 Urethane results in decreased expression of GPD1 mRNA CTD PMID:28818685 valdecoxib decreases expression EXP 6480464 valdecoxib results in decreased expression of GPD1 mRNA CTD PMID:24136188 valproic acid decreases expression ISO RGD:733156 6480464 Valproic Acid results in decreased expression of GPD1 mRNA CTD PMID:29154799 , PMID:29501571 valproic acid increases expression ISO RGD:1331950 6480464 Valproic Acid results in increased expression of GPD1 mRNA CTD PMID:24489787 vancomycin increases expression ISO RGD:1331950 6480464 Vancomycin results in increased expression of GPD1 mRNA CTD PMID:18930951 vinclozolin affects expression EXP 6480464 vinclozolin affects the expression of GPD1 mRNA CTD PMID:19015723